| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |